Shire, the London-listed rare diseases specialist that is a potential takeover target for Japan's Takeda Pharmaceutical, is selling its oncology business to unlisted French drugmaker Servier for $2.4 billion. As Pascale Davies reports, the deal suggests there is value locked up within Shire's portfolio - despite a dismal share price performance in the past two years. Video provided by Reuters


USA Today

Latest News

CNBC: Currency and pricing squeeze GlaxoSmithKline as new shingles vaccine shines

CTV News: Stocks sink again as materials costs and interest rates rise

CTV News: Finland denies media claims basic income trial fallen flat

Ynet: Pope invites Mideast religious leaders to Italy for peace summit

Ynet: Palestinian journalist shot at Gaza protest dies of wounds

Ynet: US not seeking to reopen Iran nuclear deal, envoy says

Ynet: Romania leader skips corruption hearing—by visiting Israel

CNN: CNN, news orgs ask court to unseal Manafort court documents

CNN: Congressional Republicans return to baseball practice months after shooting

CNN: Novak Djokovic suffers shock defeat to world No. 140

CBS: Meek Mill released from prison, attends 76ers game

AP: Summer Movie Preview: 'Deadpool 2' is about kindness (truly)

NewYorkTimes: Pope to Host 3 Chilean Victims of Sexual Abuse to Ask Their Forgiveness

NewYorkTimes: Life Sentence for Murder of Kim Wall

CTV News: Privacy expert warns of risks of submitting DNA to genealogy websites

FOX: Ben & Jerry's coolest summer flavor is only sold at one store

USA Today: Waffle House hero courageously took away a gun. When will Congress step up?

Daily Mail: Father turns son into police after he ADMITTED breaking into 250 cars including an officer stole gun

Daily Mail: Ronnie Pickering is floored with a single punch outside a pub - then gets up and finishes his pint 

CNBC: Markets are having an interest rate problem here, says Wharton's Jeremy Siegel

CNBC: Full interview with Jeremy Siegel

CNBC: Macron and North Korea may buy time for the Iran deal, but it will likely still collapse

WashingtonPost: Twitter Is Off the Takeover Rumor Merry-Go-Round: Gadfly